Seaport Therapeutics SPTX Income Statement
| Q1 '26 | ||
|---|---|---|
| $21.43M+103% | ||
| $6.11M+8.2% | ||
| $27.54M+70.2% | ||
| -$27.54M-70.2% | ||
| $2.13M-31.2% | ||
| $2.65M-14.1% | ||
| -$24.89M-90.1% | ||
| $519K+1,574% | ||
| -$25.41M-93.6% | ||
| -$10.34-83.0% | ||
| -$27.52M-70.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Seaport Therapeutics 's income statement data come from?
- Every line is extracted from Seaport Therapeutics 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.